• KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
  • KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
  • KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
  • KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
  • KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
  • KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
  • KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
  • KZT/USD = 0.00221
  • TJS/USD = 0.10850
  • UZS/USD = 0.00008
  • TMT/USD = 0.29760
25 October 2026

Viewing results 1 - 6 of 22

Reports of Suspected Plague in Russia Prompt Central Asian Health Checks

Reports surrounding the death of an employee at an anti-plague research institute in Russia’s Irkutsk region have prompted health authorities across Central Asia to tighten sanitary controls and review preparedness measures. Russian officials have not confirmed that the employee contracted plague or that a laboratory accident occurred. Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan have nevertheless announced additional checks or heightened readiness in response. Officials across the region say there is no cause for alarm, but the response reflects the sensitivity that remains around cross-border infectious disease threats after the COVID-19 pandemic. What Is Known Russian authorities have released few details, but reports say an employee at the anti-plague institute in Shelekhov, near Irkutsk, accidentally broke a test tube containing live bacteria. That employee, a female aged 27 or 28, was hospitalized on September 29, but she died on October 2. The hospital where she was treated was reportedly placed under quarantine, and nearly 200 people who might have come into contact with her are under medical observation. There are also reports that four more hospitals are under quarantine, with some 100 people hospitalized as a precaution. Russian officials deny these reports and say health specialists are on the ground in the area investigating and have urged the public to wait for an official assessment of the situation and not spread rumors. The Response in Central Asia Kazakhstan shares a 7,800-kilometer border with Russia; the distance from far northeastern Kazakhstan to Irkutsk is more than 1,500 kilometers. While that is comforting, the distance from Kazakhstan to Wuhan, China, is some 3,600 kilometers, and the coronavirus that originated in Wuhan in 2019 eventually reached Kazakhstan and everywhere else in the world. On October 5, Kazakhstan’s Health Ministry said it was aware of the reports from Irkutsk, was following the situation closely, and had ordered closer checks at border crossings and other entry points. “Sanitary and quarantine controls are being conducted at state border crossing points,” a Health Ministry statement said, “No individuals with elevated temperatures, signs of illness, or suspected highly dangerous infections have been detected across any mode of transport.” The Health Ministry said the chances of plague, or “pneumonia of undetermined etiology” crossing Kazakhstan’s borders were low. Kyrgyzstan’s Health Ministry also said it had ordered close checks of people entering the country in response to reports about the situation in Irkutsk. “Specialists monitor individuals, vehicles, and cargo crossing the border to prevent the importation and spread of infectious diseases, including highly dangerous infections,” the Health Ministry said. The same measures are being implemented in Tajikistan. Said Davlatzoda, the head of the Health Ministry’s Department of Sanitary-Epidemiological Safety, Emergency Situations and Emergency Medical Care, said orders went out that every person crossing into Tajikistan must have their body temperature measured. Workers from the department have been instructed to ask people arriving whether they are experiencing symptoms such as nausea and vomiting, headache, weakness, and muscle and joint pain. Personnel from the Sanitary-Epidemiological Safety Department have also been told to wear disposable hazmat...

Kyrgyzstan Tests Public Health Emergency Response Ahead of World Nomad Games

Kyrgyzstan has carried out large-scale interagency public health emergency exercises as part of preparations for the sixth World Nomad Games, which will take place from August 31 to September 6. Authorities say health security has become one of the key components of planning for what is expected to be the country's largest international event of the year. The two-day simulation exercise was held on July 14-15 in Cholpon-Ata, in the Issyk-Kul region. It brought together representatives of the Ministry of Health, healthcare institutions, the World Health Organization (WHO), other government agencies, and international development partners. Participants rehearsed the response to a simulated outbreak of acute intestinal infection and cases of an unidentified illness during a major international gathering. Field exercises were conducted in the Kyrchyn Gorge, one of the main venues for the upcoming Games, and at the infectious diseases department of the Issyk-Kul District Center for General Medical Practice. The drills tested early detection of health threats, laboratory diagnostics, medical response, interagency coordination, and crisis communication. According to Gulbara Ishenapysova, Kyrgyzstan's Deputy Minister of Health and Chief State Sanitary Doctor, the exercises provided an opportunity to assess the country's emergency response system under conditions closely resembling a real public health crisis and to identify areas requiring further improvement. Acting WHO Representative in Kyrgyzstan Zhanara Bekenova said such exercises are essential for evaluating coordination, information sharing, and decision-making mechanisms ahead of large international events. Preparations for the Games extend well beyond sports infrastructure. As previously reported by The Times of Central Asia, the 2026 World Nomad Games mark the event’s return to Kyrgyzstan. The event is also intended to promote tourism and the country’s nomadic cultural heritage internationally. Following the exercises, the Ministry of Health plans to prepare recommendations to improve interagency cooperation and the preparedness of healthcare institutions. The recommendations will also cover risk communication and revisions to national public health emergency response plans. The sixth World Nomad Games are expected to attract participants from more than 95 countries. More than 3,000 members of sporting delegations and delegations representing culture and science are expected to attend. The event is also expected to draw more than 600 domestic and international media representatives. For more from our World Nomad Games 2026 special coverage, click here.

Tajikistan’s Health Ministry Seeks Alternative to USAID Assistance in Combating Deadly Diseases

Tajikistan’s Ministry of Health is exploring alternative funding sources following the suspension of USAID programs. The recent freeze on U.S. foreign aid has affected several health initiatives in Tajikistan, particularly those focused on combating HIV/AIDS, tuberculosis, and malaria. At a press conference, Health Minister Jamoliddin Abdullozoda stated that authorities are seeking new mechanisms to sustain these programs. “USAID has played a key role in the fight against HIV, tuberculosis, malaria, as well as in maternal and child health. Until the agency’s future involvement is clarified, we intend to mobilize other resources,” Abdullozoda said. One of Tajikistan’s main partners remains the Global Fund to Fight AIDS, Tuberculosis, and Malaria, which continues to finance drug supplies and testing. The Health Ministry confirmed its commitment to strengthening cooperation with the Fund and engaging additional international organizations. Tajikistan's Republican Center for AIDS Prevention and Control clarified that USAID did not provide antiretroviral therapy (ARV) drugs or testing kits. Instead, the agency’s primary role was offering psychological and social support to HIV patients, mainly through nongovernmental organizations. According to official data, 12,480 people living with HIV are currently registered in Tajikistan’s healthcare system, including 1,022 children. In 2023, 293 new cases were detected among labor migrants. However, the overall number of registered HIV cases declined by 98 compared to previous years. Regarding tuberculosis, Tajikistan recorded 4,545 new cases in 2023 and 4,537 in 2024. The health minister attributed the slight increase to improved diagnostic capabilities. The country now has 77 tuberculosis diagnostic machines, 84 BAG laboratories, and 40 specialized devices for detecting infections.

Kyrgyzstan Gears Toward Self-Sufficiency in Medication

Kyrgyzstan has taken a significant step toward reducing its dependence on imported pharmaceuticals with the launch of domestic medicine production at the Aidan Pharma pharmaceutical plant. The facility has begun manufacturing its first batch of essential medications, including: Paracetamol (suspensions and tablets); Ibuprofen (suspensions); Acetylsalicylic acid (tablets); and Acyclovir (tablets). The plant has the capacity to produce up to 10,000 packages of each of these medicines per day, offering an important boost to the country’s pharmaceutical industry. In late 2023, Aidan Pharma began producing medical ethyl alcohol, which is now supplied to state hospitals and pharmacies. During a visit to the plant on January 10, Health Minister Alymkadyr Beishenaliev announced plans to expand the plant’s product range to 100 items by the end of this year. He also revealed that the company intends to begin exporting its products in the future. “The plant's products meet quality standards and have a low production cost, making them more affordable compared to imported medicines,” Beishenaliev noted. The Kyrgyz government has prioritized reducing the country’s reliance on imported medications. In December 2024, the Cabinet of Ministers approved an investment agreement for a Kyrgyz-Chinese pharmaceutical project led by Standard Pharm Group. This initiative will focus on packaging pharmaceuticals and constructing a new pharmaceutical plant in Kyrgyzstan. The project, which will be implemented in two stages over five years, is expected to attract over $41 million in investment. According to Minister of Economy and Commerce Bakyt Sydykov, the plant will manufacture a range of medicines, including: Nutritional infusions; Antibacterial, anti-inflammatory, and antipyretic medications; Analgesics; Hypoglycemic treatments; and Gastrointestinal drugs. Most of these medicines are included in Kyrgyzstan’s List of Vital Medicines, a critical inventory of essential pharmaceuticals that are currently not produced domestically. The development of Kyrgyzstan’s pharmaceutical industry marks a critical shift toward self-sufficiency in healthcare. By expanding domestic production, the government aims to make essential medications more accessible and affordable for its population while fostering economic growth through investment and exports.

Kazakhstan Will Not Impose Quarantine for Metapneumovirus

Aizhan Esmagambetova, head of Kazakhstan's National Center for Public Health, has announced that there is no need for restrictive measures in response to identified cases of human metapneumovirus (HMPV) in the country. Human metapneumovirus is a respiratory tract infection that can cause inflammation in the upper and lower lungs. Although the virus has been circulating among humans since the mid-20th century, it has not previously caused widespread epidemics. Concerns about the virus were raised after foreign media reported an outbreak in neighboring China in late December 2024. The Chinese Center for Disease Control and Prevention confirmed the spread of acute respiratory infections, including HMPV, but Chinese authorities did not impose border closures similar to those during the COVID-19 pandemic in 2020. In Kazakhstan, the Ministry of Health reported detecting 30 cases of metapneumovirus between October 1, 2024, and early January 2025. The Committee of Sanitary and Epidemiological Control conducted testing on 8,360 non-influenza virus samples during the epidemic season, with 1,866 (22%) returning positive. Of these, metapneumovirus accounted for only 1.6%. Other respiratory infections were more prevalent, including: Rhinovirus: 680 cases (36.4%) Respiratory syncytial (RS) virus: 433 cases (23.2%) Adenovirus: 226 cases (12.1%) Coronavirus: 206 cases (11.1%) Parainfluenza: 178 cases (9.5%) Bocavirus: 113 cases (6.1%) The Ministry of Health stated that HMPV is primarily transmitted via airborne droplets and, to a lesser extent, through household contact. Despite this, Esmagambetova emphasized there is no justification for a quarantine:"The epidemiological situation in the country is stable. While we are in the midst of the epidemic season, a comparison of this year and last year shows a 20% decrease in acute respiratory viral infections (ARVI) for the same period," she explained. "As is typical, morbidity rises in January and declines by mid-February, but there are no grounds for quarantine or other restrictive measures. We are monitoring the epidemic situation, including morbidity and virus circulation, almost daily." Esmagambetova also highlighted that approximately 70% of cases in Kazakhstan occur in children under 14. She advised parents to keep children with signs of respiratory infections at home and avoid sending them to schools or kindergartens. She further recommended that citizens avoid crowded places, wear masks, and ensure proper ventilation. Kazakhstan’s Minister of Education, Gani Beisembayev, stated during a government meeting that the country’s education system is prepared to switch to distance learning if necessary. However, any decision to transition will depend on the Ministry of Health. This update comes after The Times of Central Asia reported outbreaks of seasonal and non-seasonal diseases across Central Asia last year, including influenza, measles, and hepatitis​.

Turkmenistan Strengthens Cooperation with IAEA to Equip New Cancer Center

Turkmenistan is deepening its collaboration with the International Atomic Energy Agency (IAEA) to advance nuclear medicine, as announced by Gurbanguly Berdimuhamedov, Chairman of the Halk Maslahaty (People's Council). The announcement came during his visit to the construction site of the new International Scientific and Clinical Center for Oncology in Ashgabat, as reported by the TDH news agency. Berdimuhamedov highlighted the importance of consulting with IAEA experts to ensure the center’s safe operation, particularly in handling radioactive waste. He stressed that equipping the facility with state-of-the-art technology is essential for meeting high standards in cancer treatment. The new center, under construction in the Choganly district in northern Ashgabat, will have a capacity of 500 beds. It will feature specialized departments for the diagnosis, treatment, and rehabilitation of cancer patients. Berdimuhamedov also emphasized the need to develop highly skilled medical personnel for the center. Medical professionals will be offered training opportunities in leading international clinics and encouraged to collaborate with foreign specialists. The facility aims to build strong partnerships with specialized medical institutions both within Turkmenistan and abroad. “International cooperation, particularly with the IAEA, is vital in the fight against cancer. Strengthening these ties is a key factor in the effective operation of the new center,” Berdimuhamedov stated. The oncology center is set to greatly enhance Turkmenistan’s healthcare system by providing advanced cancer care and contributing to global progress in nuclear medicine and cancer research.